Startup Quantapore has made public several of its management team (see story, this issue). Martin Huber is co-founder and CEO. Over the last 15 years, he has held a number of positions at biotechnology startups in both Europe and the US. He holds an MS and a PhD in genetics and biochemistry from the University of Vienna.
Sascha Dennstedt is co-founder and president, and will be responsible for business planning and development efforts. Dennstedt is an entrepreneur who has invested in multiple biotechnology startups.
Deryl Banks is chief financial officer. He is currently the life science practice leader at the Brenner Group. He has started and managed finance departments at four medical device startups over the last 15 years.
Michael Chen is the company's director of engineering. Chen is a visiting scholar at Stanford University's Department of Electrical Engineering.
Pacific Biosciences has appointed Marshall Mohr to its board of directors and to serve on its audit committee. Mohr has been senior vice president and chief financial officer of Intuitive Surgical since March 2006. Previously, he served as vice president and chief financial officer of Adaptec, and has also been an audit partner with PricewaterhouseCoopers. He is also a board member and chairman of the audit committee for Plantronics. Mohr will receive an annual retainer of $35,000 as well as an additional $10,000 retainer for his service on the audit committee.
Helicos Biosciences has elected Bruce Ginsberg to its board of directors to review certain financing matters. Ginsberg is president and CEO of MooBella, a food service provider, and a member of the board of directors of Mac-Gray.